SKIC2: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

Target Name: SKIC2

NCBI ID: G6499

SKIC2

SKIC2: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

SKIC2, short for SKI2, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-1 family, which includes proteins that play a crucial role in the immune response and inflammation. The SKIC2 protein has been shown to be involved in the regulation of inflammation and has potential as a drug target or biomarker for the treatment of inflammatory diseases.

SKIC2 has been shown to be involved in the regulation of cytokine signaling pathways, which are critical for the initiation and regulation of the immune response. It has been shown to play a role in the regulation of T cell development and function, and has been shown to be involved in the regulation of the production of pro-inflammatory cytokines.

SKIC2 has also been shown to be involved in the regulation of inflammation in the brain, which is a critical site of inflammation and is involved in the development and progression of many inflammatory diseases, including Alzheimer's disease and multiple sclerosis. It has been shown to play a role in the regulation of neuroinflammation and has been shown to be involved in the development of neurodegeneration.

SKIC2 has also been shown to be involved in the regulation of inflammation in the skin, which is a site of chronic inflammation and is involved in the development and progression of many inflammatory diseases, including psoriasis and acne. It has been shown to play a role in the regulation of skin inflammation and has been shown to be involved in the development of skin deformities.

In conclusion, SKIC2 is a protein that is involved in the regulation of inflammation and has potential as a drug target or biomarker for the treatment of inflammatory diseases. Further research is needed to fully understand the role of SKIC2 in inflammation and to develop effective treatments for inflammatory diseases based on this understanding.

Protein Name: SKI2 Subunit Of Superkiller Complex

Functions: Helicase; has ATPase activity (PubMed:7610041). Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1 complex (PAF1C) (PubMed:16024656)

The "SKIC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SKIC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets